Assessment of tumor-infiltrating lymphocytes (TILs) is increasingly recognized as an integral part of the prognostic workflow in triple-negative (TNBC) and HER2-positive breast cancer, as well as many other solid tumors. This recognition has come about thanks to standardized visual reporting guideli...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!